Peregrine Investment Management Inc Beam Therapeutics Inc. Transaction History
Peregrine Investment Management Inc
- $156 Billion
- Q2 2025
A detailed history of Peregrine Investment Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Peregrine Investment Management Inc holds 264,260 shares of BEAM stock, worth $4.66 Million. This represents 2.87% of its overall portfolio holdings.
Number of Shares
264,260
Previous 224,260
17.84%
Holding current value
$4.66 Million
Previous $4.38 Billion
2.63%
% of portfolio
2.87%
Previous 3.27%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
94.9MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$175 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$171 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$156 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$135 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$83.3 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.24B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...